Omnicell (OMCL)
(Delayed Data from NSDQ)
$28.43 USD
+0.64 (2.30%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $28.46 +0.03 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Price, Consensus and EPS Surprise
OMCL 28.43 +0.64(2.30%)
Will OMCL be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for OMCL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OMCL
Here's Why You Should Retain Omnicell (OMCL) Stock Now
Omnicell (OMCL) Q4 Earnings Top Estimates, Gross Margin Down
OMCL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Omnicell (OMCL) Tops Q4 Earnings and Revenue Estimates
Here's Why You Should Retain Omnicell (OMCL) Stock Now
Omnicell (OMCL) Gains From Innovation Amid Cost Pressure
Other News for OMCL
Clover Health appoints Peter Kuipers as CFO
Omnicell (OMCL) Receives a Buy from Craig-Hallum
Omnicell’s Strategic Shift to Recurring Revenue: A Cautious Hold Amidst Transformation Uncertainty
Omnicell Announces XT Amplify
Omnicell announces XT Amplify